Tuberculous meningitis (TBM) is the most devastating form of tuberculosis (TB), causing
high mortality or disability. Clinical management of the disease is challenging due to …

Non-coding RNAs have emerged as critical regulators of the immune response to infection.
MicroRNAs (miRNAs) are small non-coding RNAs which regulate host defense mechanisms …

Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is one of the most
lethal infectious disease worldwide, and it greatly affects human health. Some diagnostic …

The end TB strategy reinforces the essentiality of readily accessible biomarkers for early
tuberculosis diagnosis. Exploration of microRNA (miRNA) and pathway analysis opens an …

Tuberculosis (TB) is one of the most fatal infectious diseases, affecting one third of the
world's population. The causative agent, Mycobacterium tuberculosis (Mtb), has a well …

Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is
proteolytically processed in multiple pathological conditions. However, no biological function …

Tuberculosis (TB) continues to threaten many peoples' health worldwide, regardless of their
country of residence or age. The current diagnosis of TB still uses mainly traditional, time …

Proteomics is playing an increasingly important role in identifying pathogens, emerging and
re-emerging infectious agents, understanding pathogenesis, and diagnosis of diseases …

Tuberculosis (TB) is a deadly infectious disease that affects millions of people globally. TB
proteomics signature discovery has been a rapidly growing area of research that aims to …

Background The early diagnosis of tuberculosis using novel non-sputum-based biomarkers
is of high priority in the End TB strategy. MicroRNAs (miRNAs) are significant regulators of …